Wu Lang, Xiang Xin, Zhang Long, Chen Yafang, Yu Xiang, He Kang
College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, China.
Chem Biodivers. 2025 Feb;22(2):e202401971. doi: 10.1002/cbdv.202401971. Epub 2024 Nov 9.
Funtumine is a pregnene-type steroidal alkaloid exhibiting moderate anticancer activity. To discover novel natural product-based anticancer drugs, a series of novel funtumine amide/sulfonamide derivatives were papered and identified using spectroscopic techniques. Additionally, the structures of compounds 2j, 3a, and 4k were further confirmed through X-ray diffraction analysis. Biological activity experiments conducted against three cancer cell lines revealed that several of the synthesized compounds demonstrated inhibition activities comparable to or exceeding those of the commercial anticancer agent, 5-Fluorouracil. Especially compound 4i demonstrated a notably strong growth inhibitory effect on HePG2 (IC=14.89 μM) and HCT116 (IC=15.67 μM) cell lines, while exhibiting minimal cytotoxicity towards human normal BEAS-2B cells. Preliminary structure-activity relationships (SARs) analysis indicated that the conversion of the carbonyl group at the C-20 position of funtumine to a hydroxyl group could yield more potent compounds.
丰土明是一种具有中等抗癌活性的孕烯类甾体生物碱。为了发现新型基于天然产物的抗癌药物,我们设计并通过光谱技术鉴定了一系列新型丰土明酰胺/磺酰胺衍生物。此外,化合物2j、3a和4k的结构通过X射线衍射分析得到进一步证实。针对三种癌细胞系进行的生物活性实验表明,几种合成化合物表现出与商业抗癌药物5-氟尿嘧啶相当或更强的抑制活性。特别是化合物4i对HePG2(IC = 14.89 μM)和HCT116(IC = 15.67 μM)细胞系表现出显著的强生长抑制作用,而对人正常BEAS-2B细胞的细胞毒性极小。初步的构效关系(SARs)分析表明,将丰土明C-20位的羰基转化为羟基可产生更有效的化合物。